India · Delayed Price · Currency is INR Senores Pharmaceuticals Statistics
Total Valuation
BOM:544319 has a market cap or net worth of INR 34.33 billion. The enterprise value is 33.88 billion.
| Market Cap | 34.33B |
| Enterprise Value | 33.88B |
Important Dates
The next estimated earnings date is Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 46.05M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +208.55% |
| Shares Change (QoQ) | -8.35% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 19.35M |
Valuation Ratios
The trailing PE ratio is 50.81 and the forward PE ratio is 31.13.
| PE Ratio | 50.81 |
| Forward PE | 31.13 |
| PS Ratio | 7.53 |
| PB Ratio | 4.23 |
| P/TBV Ratio | 6.07 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 50.15 |
| EV / Sales | 7.43 |
| EV / EBITDA | 32.99 |
| EV / EBIT | 40.70 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.39 |
| Debt / EBITDA | 3.06 |
| Debt / FCF | n/a |
| Interest Coverage | 3.82 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 23.50M |
| Profits Per Employee | 3.48M |
| Employee Count | 194 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:544319 has paid 149.80 million in taxes.
| Income Tax | 149.80M |
| Effective Tax Rate | 17.92% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 651.30 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 59.97 |
| Average Volume (20 Days) | 19,929 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:544319 had revenue of INR 4.56 billion and earned 675.60 million in profits. Earnings per share was 17.26.
| Revenue | 4.56B |
| Gross Profit | 2.48B |
| Operating Income | 832.50M |
| Pretax Income | 835.90M |
| Net Income | 675.60M |
| EBITDA | 1.03B |
| EBIT | 832.50M |
| Earnings Per Share (EPS) | 17.26 |
Balance Sheet
The company has 3.86 billion in cash and 3.15 billion in debt, giving a net cash position of 707.50 million.
| Cash & Cash Equivalents | 3.86B |
| Total Debt | 3.15B |
| Net Cash | 707.50M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 8.12B |
| Book Value Per Share | 168.00 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 54.49%, with operating and profit margins of 18.26% and 14.82%.
| Gross Margin | 54.49% |
| Operating Margin | 18.26% |
| Pretax Margin | 18.34% |
| Profit Margin | 14.82% |
| EBITDA Margin | 22.53% |
| EBIT Margin | 18.26% |
| FCF Margin | n/a |
Dividends & Yields
BOM:544319 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -208.55% |
| Shareholder Yield | n/a |
| Earnings Yield | 1.97% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |